On the other hand, expressions of AXIN2, MLH1, RNF43, and EPM2AIP1 were significantly downregulated in BRAF V600E-mutant CRC, versus either KRAS/BRAF wide-type or KRAS mutant CRC (Fig. S1B). Here, KRAS is linked to colorectal carcinoma.